Abstract
BackgroundImmunotherapy for pancreatic cancer (PC) is inefficient due to a highly immune-suppressive tumor microenvironment (TME) orchestrated by myeloid suppressor cells, which limit the infiltration and function of cytotoxic immune cells....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have